In contrast to the murine simulations, cancer cells in the human simulations were allowed to stochastically gain new neoantigens, lose expression of existing neoantigens, and lose MHC expression (see Methods, S2A Fig) [10,11]. The gene discussed is HLA-C; the disease is cancer.